HPV-negative cervical cancer
Scope
Date
~
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Corporate bonds
Korean firms at risk of credit rating downgrade on Legoland woes
South Korean companies are at risk of credit rating downgrades as the fallout of a debt default by the domestic developer of a Legoland theme park r...
Nov 13, 2022 (Gmt+09:00)
-
Economy
Sinking won fans doubts over Korea’s economic fundamentals
The tanking South Korean won currency has stoked doubts over the fundamentals of Asia’s fourth-largest economy, although the government contin...
Sep 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
Food & Beverage
Starbucks Korea conducts voluntary recall on giveaway items
Starbucks Korea, owned by South Korean retail juggernaut E-Mart, conducts a voluntary recall of its line of summer travel bags, following health c...
Aug 11, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Corporate investment
SK units at risk of rating cuts on aggressive investments
South Korea’s SK Group units focusing on investments in new eco-friendly industries are facing risks of credit rating downgrades.Investors hav...
Mar 10, 2022 (Gmt+09:00)
-
Automobiles
Hyundai, Kia heavily exposed to Ukraine crisis; shares at 52-week lows
Shares of Hyundai Motor Co. and Kia Corp. on Monday fell to their lowest levels in more than 52 weeks as investors engaged in panic selling on conce...
Feb 28, 2022 (Gmt+09:00)
-
Earnings
Hyundai Heavy's KSOE posts $1.1 bn loss in 2021
Korea Shipbuilding & Offshore Engineering Co. (KSOE), under Hyundai Heavy Industries Group, on Monday reported a bigger-than-expected operating ...
Feb 07, 2022 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Batteries
LG Chem shares rise as GM resumes battery module replacement
Shares of LG Chem Ltd. are staging a rebound a month after falling sharply due to a decision by General Motors Co. to recall 73,000 Chevrolet Bolt e...
Sep 24, 2021 (Gmt+09:00)
-
Biotech
JW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Pension funds
Korean pension funds log above-benchmark H1 returns
South Korea's major pension funds have posted robust investment returns above their benchmarks in the first half of this year, driven by double-digi...
Aug 09, 2021 (Gmt+09:00)
-
Biotech
IMB Dx eyes platform to detect stage 1 cancer with single draw of blood
IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...
Jul 22, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
ESG
NPS adopts limited negative screening on high emitters
South Korea's National Pension Service (NPS) decided on Friday to exclude from its portfolio new coal-fired power development projects both at home ...
May 28, 2021 (Gmt+09:00)
-
Pension funds
CPPIB says no negative screening for ESG investing
The Canada Pension Plan Investment Board (CPPIB) does not carry out negative screening to exclude companies and sectors that do not comply with envi...
May 27, 2021 (Gmt+09:00)
-
ESG
NPS shelves plan for negative screening on high emitters
The National Pension Service has shelved a plan to introduce negative screening on coal mines and relevant businesses in an aim to build a low-carbo...
Apr 30, 2021 (Gmt+09:00)
-
ESG bonds
Hana Bank issues $600 mn euro-currency bonds with negative yield
Hana Bank has become South Korea’s first commercial bank to issue foreign currency bonds at a negative yield, raising 500 million euros ($606 ...
Jan 21, 2021 (Gmt+09:00)
-
Korean stock market
Investors eye Goldilocks stock market in 2021; Biden, pandemic negatives
South Korea’s stock markets are expected to continue their uptrend into next year, fueled by aggressive foreign buying on the back of strong cor...
Nov 17, 2020 (Gmt+09:00)
-
Airlines
Largest domestic carrier Korean Air posts Q3 surplus; peers swing negative
South Korea’s flag carrier Korean Air Lines Co. has posted an operating profit for two straight quarters thanks to robust cargo operations keepi...
Nov 05, 2020 (Gmt+09:00)
-
Debt
Export-Import Bank of Korea sells $500 mn euro bonds with negative yield
The Export-Import Bank of Korea (KEXIM) has issued euro-currency bonds worth $500 million at a negative interest rate, the bank said on Sept. 15, less...
Sep 15, 2020 (Gmt+09:00)
-
Sovereign bond
South Korea sells $827 mn worth of euro-currency bonds with negative yield
The South Korean government has issued euro-denominated bonds worth 700 million euros ($827 million) at a negative interest rate, becoming the first n...
Sep 10, 2020 (Gmt+09:00)
-
Asset allocation
NPS logs negative Q1 investment return on stock market plunge
The National Pension Service (NPS) reported a negative 6.08% return on investment in the first three months of this year, weighed down by double-digit...
Jun 01, 2020 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand